RESUMO
PURPOSE: Polysomnography is not recommended for children at home and does not adequately capture partial upper airway obstruction (snoring and stertor), the dominant pathology in pediatric sleep-disordered breathing. New methods are required for assessment. Aims were to assess sleep disruption linked to partial upper airway obstruction and to evaluate unattended Sonomat use in a large group of children at home. METHODS: Children with suspected obstructive sleep apnea (OSA) had a single home-based Sonomat recording (n = 231). Quantification of breath sound recordings allowed identification of snoring, stertor, and apneas/hypopneas. Movement signals were used to measure quiescent (sleep) time and sleep disruption. RESULTS: Successful recordings occurred in 213 (92%) and 113 (53%) had no OSA whereas only 11 (5%) had no partial obstruction. Snore/stertor occurred more frequently (15.3 [5.4, 30.1] events/h) and for a longer total duration (69.9 min [15.7, 140.9]) than obstructive/mixed apneas and hypopneas (0.8 [0.0, 4.7] events/h, 1.2 min [0.0, 8.5]); both p < 0.0001. Many non-OSA children had more partial obstruction than those with OSA. Most intervals between snore and stertor runs were < 60 s (79% and 61% respectively), indicating that they occur in clusters. Of 14,145 respiratory-induced movement arousals, 70% were preceded by runs of snore/stertor with the remainder associated with apneas/hypopneas. CONCLUSIONS: Runs of snoring and stertor occur much more frequently than obstructive apneas/hypopneas and are associated with a greater degree of sleep disruption. Children with and without OSA are frequently indistinguishable regarding the amount, frequency, and the degree of sleep disturbance caused by snoring and stertor.
Assuntos
Polissonografia , Apneia Obstrutiva do Sono/epidemiologia , Transtornos do Sono-Vigília/epidemiologia , Ronco/epidemiologia , Criança , Correlação de Dados , Estudos Transversais , Humanos , Reprodutibilidade dos Testes , Apneia Obstrutiva do Sono/diagnóstico , Transtornos do Sono-Vigília/diagnóstico , Ronco/diagnósticoRESUMO
Positive airway pressure (PAP) treatment has been shown to have a modest effect on ambulatory blood pressure (BP) in patients with obstructive sleep apnea (OSA). However, there is a paucity of data on the effect of PAP therapy on rapid, yet significant, BP swings during sleep, particularly in obesity hypoventilation syndrome (OHS). The present study hypothesizes that PAP therapy will improve nocturnal BP on the first treatment night (titration PAP) in OHS patients with underlying OSA, and that these improvements will become more significant with 6 wk of PAP therapy. Seventeen adults (7 men, 10 women; age 50.4 ± 10.7 years, BMI 49.3 ± 2.4 kg/m(2)) with OHS and clinically diagnosed OSA participated in three overnight laboratory visits that included polysomnography and beat-to-beat BP monitoring via finger plethysmography. Six weeks of PAP therapy, but not titration PAP, lowered mean nocturnal BP. In contrast, when nocturnal beat-to-beat BPs were aggregated into bins consisting of at least three consecutive cardiac cycles with a >10 mmHg BP surge (i.e., Δ10-20, Δ20-30, Δ30-40, and Δ>40 mmHg), titration, and 6-wk PAP reduced the number of BP surges per hour (time × bin, P < 0.05). PAP adherence over the 6-wk period was significantly correlated to reductions in nocturnal systolic (r = 0.713, P = 0.001) and diastolic (r = 0.497, P = 0.043) BP surges. Despite these PAP-induced improvements in nocturnal beat-to-beat BP surges, 6 wk of PAP therapy did not alter daytime BP. In conclusion, PAP treatment reduces nocturnal beat-to-beat BP surges in OHS patients with underlying OSA, and this improvement in nocturnal BP regulation was greater in patients with higher PAP adherence.
Assuntos
Pressão Sanguínea , Síndrome de Hipoventilação por Obesidade/fisiopatologia , Síndrome de Hipoventilação por Obesidade/terapia , Respiração com Pressão Positiva/métodos , Apneia Obstrutiva do Sono/fisiopatologia , Apneia Obstrutiva do Sono/terapia , Chicago , Feminino , Frequência Cardíaca , Humanos , Masculino , Pessoa de Meia-Idade , Síndrome de Hipoventilação por Obesidade/diagnóstico , Apneia Obstrutiva do Sono/diagnóstico , Resultado do TratamentoRESUMO
STUDY OBJECTIVES: The success of surgical treatment for pediatric sleep-disordered breathing is typically assessed using the mixed and obstructive apnea-hypopnea index (MOAHI). Although an important metric, previous work has shown that snoring and stertor are also associated with sleep disruption. Our aim was to assess the efficacy of surgery using the Sonomat (Sonomedical Pty Ltd), a noncontact sleep assessment system, that accurately records complete and partial upper airway obstruction. METHODS: Forty children (< 18 years) had a Sonomat study, in their own beds, before and after surgery. As an MOAHI ≥ 1 event/h is considered abnormal, the same threshold was applied to snore/stertor runs. Median (interquartile range) values are reported. RESULTS: Respiratory event-induced movements decreased from 12.0 (8.7-19.0) to 0.5 (0.1-3.2) events/h (P < .01), with no significant change in spontaneous movements: 12.8 (9.8-17.9) to 16.5 (13.7-26.1) events/h (P = .07). The MOAHI decreased from 4.5 (1.9-8.6) to 0.0 (0.0-0.4) events/h (P < .01). Snoring and/or stertor runs decreased from 32.8 (23.4-44.4) to 3.0 (0.2-14.6) events/h (P < .01). Thirty-four children had an MOAHI < 1 event/h following surgery; however, 20 had snore and/or stertor runs ≥ 1 event/h and 11 had snore and/or stertor runs ≥ 5 events/h. Only 14 (35%) children had a postsurgery MOAHI < 1 event/h combined with snoring and/or stertor < 1 runs/h. CONCLUSIONS: Although surgery is effective in improving breathing, success rates are overestimated using the MOAHI. Our results indicate that snoring and/or stertor are still present at levels that may disrupt sleep despite a normalization of the MOAHI and that when obstructed breathing was objectively measured, there was a large variation in its response to surgery. CITATION: Norman MB, Harrison HC, Sullivan CE, Milross MA. Measurement of snoring and stertor using the Sonomat to assess effectiveness of upper airway surgery in children. J Clin Sleep Med. 2022;18(6):1649-1656.
Assuntos
Síndromes da Apneia do Sono , Apneia Obstrutiva do Sono , Criança , Humanos , Nariz , Sono/fisiologia , Síndromes da Apneia do Sono/diagnóstico , Síndromes da Apneia do Sono/cirurgia , Apneia Obstrutiva do Sono/diagnóstico , Apneia Obstrutiva do Sono/cirurgia , Ronco/cirurgiaRESUMO
OBJECTIVE: The objective of this study was to determine what impact the omission of respiratory events scored during wake epochs has on the generation of the apnea/hypopnea index (AHI) using computerised polysomnography (PSG). MATERIALS AND METHODS: Sixty diagnostic PSG recordings were scored using the recommended method of sleep staging with epochs. In addition, absolute sleep scoring criteria was used to calculate the total sleep time (TST). The TST, respiratory events and AHI generated from both scoring methods were compared. RESULTS: The AHI from epoch scoring (AHI(EP)) was significantly less than that derived from absolute sleep staging (AHI(ABS)) [AHI(EP) = 15.8 events/hour (7.3, 38.2), AHI(ABS) = 18.8 events/hour (8.7, 40.2); p < 0.0001]. From a total of 8,820 legitimately scored respiratory events ≥10 s duration, 723 (8%) were excluded from the AHI(EP) calculation as they were identified as having occurred during wake, but 400 of these (57%) started in an epoch of wake and continued into epoch(s) of sleep. These omitted events were not trivial [median 16.6 s (13.0, 24.0)] and were frequently associated with oxygen desaturation events [median 4% (3.0, 7.0)] with a range of 3% to 39%. CONCLUSION: The use of arbitrarily defined epochs for sleep staging has a direct impact on legitimately scored respiratory events resulting in the systematically incorrect reporting of the AHI. This artefact is due to computerised data reduction excluding all respiratory events that are contained within an epoch(s) of wake as well as those that start in an epoch scored as wake.
Assuntos
Diagnóstico por Computador/instrumentação , Diagnóstico por Computador/estatística & dados numéricos , Polissonografia/instrumentação , Polissonografia/estatística & dados numéricos , Processamento de Sinais Assistido por Computador/instrumentação , Apneia Obstrutiva do Sono/diagnóstico , Fases do Sono , Adulto , Idoso , Idoso de 80 Anos ou mais , Artefatos , Erros de Diagnóstico , Feminino , História Antiga , Serviços de Assistência Domiciliar/estatística & dados numéricos , Humanos , Masculino , Pessoa de Meia-Idade , Monitorização Ambulatorial/instrumentação , Monitorização Ambulatorial/estatística & dados numéricosRESUMO
The aim of this study was to examine sleep architecture at high altitude and its relationship to periodic breathing during incremental increases in altitude. Nineteen normal, sea level-dwelling volunteers were studied at sea level and five altitudes in the Nepal Himalaya. Morning arterial blood gases and overnight polysomnography were performed in 14 subjects at altitudes: 0, 1400, 3500, 3900, 4200 and 5000 m above sea level. Subjects became progressively more hypoxic, hypocapnic and alkalinic with increasing altitude. As expected, sleep architecture was affected by increasing altitude. While time spent in Stage 1 non-rapid eye movement sleep increased at 3500 m and higher (P < 0.001), time spent in slow-wave sleep (SWS) decreased as altitude increased. Time spent in rapid eye movement (REM) sleep was well preserved. In subjects who developed periodic breathing during sleep at one or more altitudes (16 of 19), arousals because of periodic breathing predominated, contributing to an increase in the total arousal index. However, there were no differences in sleep architecture or sleeping oxyhaemoglobin saturation between subjects who developed periodic breathing and those who did not. As altitude increased, sleep architecture became progressively more disturbed, with Stage 1 and SWS being affected from 3500 m, while REM sleep was well preserved. Periodic breathing was commonplace at all altitudes, and while associated with increases in arousal indices, did not have any apparent effect on sleep architecture.
Assuntos
Doença da Altitude/fisiopatologia , Altitude , Comportamento Competitivo , Montanhismo , Fases do Sono/fisiologia , Aclimatação/fisiologia , Adulto , Doença da Altitude/diagnóstico , Artérias , Gasometria , Ritmo Circadiano/fisiologia , Eletroencefalografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Nepal , Consumo de Oxigênio/fisiologia , Polissonografia , Respiração , Sono/fisiologia , Inquéritos e Questionários , Adulto JovemRESUMO
UNLABELLED: Overnight oxyhaemoglobin desaturation is related to AMS. AMS can be debilitating and may require descent. Positive pressure ventilation during sleep at high altitude may prevent AMS and therefore be useful in people travelling to high altitude, who are known to suffer from AMS. BACKGROUND AND OBJECTIVE: Ascent to high altitude results in hypobaric hypoxia and some individuals will develop acute mountain sickness (AMS), which has been shown to be associated with low oxyhaemoglobin saturation during sleep. Previous research has shown that positive end-expiratory pressure by use of expiratory valves in a face mask while awake results in a reduction in AMS symptoms and higher oxyhaemoglobin saturation. We aimed to determine whether positive pressure ventilation would prevent AMS by increasing oxygenation during sleep. METHODS: We compared sleeping oxyhaemoglobin saturation and the incidence and severity of AMS in seven subjects sleeping for two consecutive nights at 3800 m above sea level using either non-invasive positive pressure ventilation that delivered positive inspiratory and expiratory airway pressure via a face mask, or sleeping without assisted ventilation. The presence and severity of AMS were assessed by administration of the Lake Louise questionnaire. RESULTS: We found significant increases in the mean and minimum sleeping oxyhaemoglobin saturation and decreases in AMS symptoms in subjects who used positive pressure ventilation during sleep. Mean and minimum sleeping SaO2 was lower in subjects who developed AMS after the night spent without positive pressure ventilation. CONCLUSIONS: The use of positive pressure ventilation during sleep at 3800 m significantly increased the sleeping oxygen saturation; we suggest that the marked reduction in symptoms of AMS is due to this higher sleeping SaO2. We agree with the findings from previous studies that the development of AMS is associated with a lower sleeping oxygen saturation.
Assuntos
Doença da Altitude/sangue , Doença da Altitude/epidemiologia , Oxiemoglobinas/metabolismo , Respiração com Pressão Positiva , Sono/fisiologia , Doença da Altitude/prevenção & controle , Dióxido de Carbono/metabolismo , Feminino , Inquéritos Epidemiológicos , Humanos , Incidência , Masculino , Oxigênio/metabolismo , Troca Gasosa Pulmonar/fisiologia , Índice de Gravidade de Doença , Adulto JovemRESUMO
INTRODUCTION: Pediatric sleep disordered breathing (SDB) is characterized by long periods of partial upper airway obstruction (UAO) with low apnea-hypopnea indices (AHI). By measuring snoring and stertor, Sonomat studies allow quantification of these periods of partial UAO. AIM: To determine whether transcutaneous CO2 (TcCO2 ) levels correlate with increasing levels of partial UAO and to examine patterns of ΔTcCo2 in the transitions from (a) wakefulness to sleep and (b) non-rapid eye movement (NREM) to rapid eye movement (REM) sleep. METHODS: This was a retrospective review of sleep studies in seven asymptomatic controls aged 7 to 12 years and 62 symptomatic children with suspected SDB and no comorbidities, aged 2 to 13 years. Both groups underwent overnight polysomnography, including continuous TcCO2 , at one of two pediatric hospitals in Sydney. Changes in carbon dioxide levels between wake to NREM (sleep onset) and NREM to REM sleep were evaluated using an all-night TcCO2 trace time-linked to a hypnogram. Paired Sonomat recordings were used to quantify periods of UAO in the symptomatic group. RESULTS: The ΔTcCO2 at sleep onset was greater in SDB children than controls and ΔTcCO2 with sleep onset correlated with the duration of partial obstruction (r = .60; P < .0001). Children with an increase in TcCO2 from NREM to REM had a higher number of snoring and stertor events compared to those in whom TcCO2 decreased from NREM to REM (91 vs 30 events/h; P = < .0001). CONCLUSIONS: In children without comorbidities, the measurement of TcCO2 during sleep correlates with indicators of partial obstruction.
Assuntos
Obstrução das Vias Respiratórias/diagnóstico , Dióxido de Carbono/metabolismo , Síndromes da Apneia do Sono/diagnóstico , Adolescente , Obstrução das Vias Respiratórias/metabolismo , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Polissonografia , Estudos Retrospectivos , Sono/fisiologia , Síndromes da Apneia do Sono/metabolismo , Ronco/metabolismoRESUMO
BACKGROUND AND OBJECTIVE: While recent meta-analyses suggest that OSA elevates daytime blood pressure (BP), most studies have included patients with mild hypertension, so CPAP treatment has only reduced BP by 2-3 mm Hg. To determine the strength of the OSA-BP relationship, this study examined the effect of CPAP in a cohort where severe OSA and under-treated hypertension coexist. METHODS: Baseline demographic and sleep study data were recorded in 221 consecutive patients referred for sleep studies in Samoa. OSA was treated with CPAP and BP recorded for 6-7 months in 180 patients. A subgroup of 64 patients, representative of the entire group, but with regular follow-up, is also described. RESULTS: OSA was diagnosed in 218/221 patients; of those who commenced CPAP, 180 returned for follow-up at least once within 7 months. Following CPAP, BP decreased by 7.1/5.9 mm Hg at 1 month and 12.9/10.5 mm Hg at 6 months (n = 180, P < 0.0001). In the 64 patients with regular follow-up, those with the highest baseline BP had the greatest fall in BP with CPAP; BP in the hypertensive subgroup (32/64) decreased 21.5/13.1 mm Hg at 6 months (P < 0.0001). CONCLUSIONS: Hypertensive OSA patients can exhibit large falls in BP with CPAP at 1 month, with further significant reductions at 3 and 6 months. Overall, the fall in BP was proportional to the initial elevation of the BP with many patients achieving normal BP at 6 months.
Assuntos
Pressão Sanguínea/fisiologia , Pressão Positiva Contínua nas Vias Aéreas , Hipertensão/fisiopatologia , Hipertensão/terapia , Apneia Obstrutiva do Sono/terapia , Adulto , Estudos Transversais , Feminino , Seguimentos , Humanos , Hipertensão/etiologia , Estudos Longitudinais , Masculino , Pessoa de Meia-Idade , Samoa , Apneia Obstrutiva do Sono/complicações , Resultado do TratamentoRESUMO
Study Objectives: To validate the Sonomat against polysomnography (PSG) metrics in children and to objectively measure snoring and stertor to produce a quantitative indicator of partial upper airway obstruction that accurately reflects the pathology of pediatric sleep-disordered breathing (SDB). Methods: Simultaneous PSG and Sonomat recordings were performed in 76 children (46 male, age 5.8 ± 2.8, BMI = 18.5 ± 3.8 kg/m2). Sleep time, individual respiratory events and the apnea/hypopnea index (AHI) were compared. Obstructed breathing sounds were measured from the unobtrusive non-contact experimental device. Results: There was no significant difference in total sleep time (TST), respiratory events or AHI values, the latter over-estimated by 0.3 events hr-1 by the Sonomat. Poor signal quality was minimal and gender, BMI, and body position did not adversely influence event detection. Obstructive and central events were classified correctly. The number of runs and duration of snoring (13 399 events, 20% TST) and stertor (5748 events, 24% TST) were an order of magnitude greater than respiratory events (1367 events, 1% TST). Many children defined as normal by PSG had just as many or more runs of snoring and stertor as those with mild, moderate and severe obstructive sleep apnea (OSA). Conclusions: The Sonomat accurately diagnoses SDB in children using current metrics. In addition, it permits quantification of partial airway obstruction that can be used to better describe pediatric SDB. Its non-contact design makes it ideal for use in children.
Assuntos
Obstrução das Vias Respiratórias/diagnóstico , Polissonografia , Síndromes da Apneia do Sono/diagnóstico , Síndromes da Apneia do Sono/fisiopatologia , Apneia Obstrutiva do Sono/fisiopatologia , Criança , Pré-Escolar , Feminino , Humanos , Masculino , Polissonografia/instrumentação , Polissonografia/métodos , Sistema Respiratório/fisiopatologia , Sono/fisiologia , Apneia Obstrutiva do Sono/diagnóstico , Ronco/fisiopatologiaRESUMO
BACKGROUND: Health-care workers are concerned about the risk of acquiring contagious diseases such as severe acute respiratory syndrome and avian influenza after recent outbreaks. We studied exhaled air and particle dispersion through an oronasal mask attached to a human-patient simulator (HPS) during noninvasive positive-pressure ventilation (NPPV). METHODS: Airflow was marked with intrapulmonary smoke for visualization. Therapy with inspiratory positive airway pressure (IPAP) was started at 10 cm H2O and gradually increased to 18 cm H2O, whereas expiratory positive airway pressure was maintained at 4 cm H2O. A leakage jet plume was revealed by a laser light sheet and images captured by video. Smoke concentration in the plume was estimated from the light scattered by smoke particles. FINDINGS: A jet plume of air leaked through the mask exhaust holes to a radial distance of 0.25 m from the mask during the application of IPAP at 10 cm H2O with some leakage from the nasal bridge. The leakage plume exposure probability was highest about 60 to 80 mm lateral to the median sagittal plane of the HPS. Without nasal bridge leakage, the jet plume from the exhaust holes increased to a 0.40-m radius from the mask, whereas exposure probability was highest about 0.28 m above the patient. When IPAP was increased to 18 cm H2O, the vertical plume extended to 0.45 m above the patient with some horizontal spreading along the ward ceiling. CONCLUSION: Substantial exposure to exhaled air occurs within a 0.5-m radius of patients receiving NPPV. Medical wards should be designed with an architectural aerodynamics approach and knowledge of air/particle dispersion from common mechanical ventilatory techniques.
Assuntos
Modelos Biológicos , Modelos Teóricos , Respiração com Pressão Positiva/instrumentação , Respiração com Pressão Positiva/métodos , Movimentos do Ar , Poluição do Ar em Ambientes Fechados/prevenção & controle , Falha de Equipamento , Expiração/fisiologia , Humanos , Transmissão de Doença Infecciosa do Paciente para o Profissional/prevenção & controle , Influenza Humana/fisiopatologia , Influenza Humana/transmissão , Influenza Humana/virologia , Máscaras/virologia , Estimulação Física/métodos , Síndrome Respiratória Aguda Grave/fisiopatologia , Síndrome Respiratória Aguda Grave/transmissão , Síndrome Respiratória Aguda Grave/virologiaRESUMO
BACKGROUND: There is increasing evidence that obstructive sleep apnea (OSA) is an independent risk factor for arterial hypertension. Because there are no controlled studies showing a substantial effect of nasal continuous positive airway pressure (nCPAP) therapy on hypertension in OSA, the impact of treatment on cardiovascular sequelae has been questioned altogether. Therefore, we studied the effect of nCPAP on arterial hypertension in patients with OSA. METHODS AND RESULTS: Sixty consecutive patients with moderate to severe OSA were randomly assigned to either effective or subtherapeutic nCPAP for 9 weeks on average. Nocturnal polysomnography and continuous noninvasive blood pressure recording for 19 hours was performed before and with treatment. Thirty two patients, 16 in each group, completed the study. Apneas and hypopneas were reduced by approximately 95% and 50% in the therapeutic and subtherapeutic groups, respectively. Mean arterial blood pressure decreased by 9.9+/-11.4 mm Hg with effective nCPAP treatment, whereas no relevant change occurred with subtherapeutic nCPAP (P=0.01). Mean, diastolic, and systolic blood pressures all decreased significantly by approximately 10 mm Hg, both at night and during the day. CONCLUSIONS: Effective nCPAP treatment in patients with moderate to severe OSA leads to a substantial reduction in both day and night arterial blood pressure. The fact that a 50% reduction in the apnea-hypopnea index did not result in a decrease in blood pressure emphasizes the importance of highly effective treatment. The drop in mean blood pressure by 10 mm Hg would be predicted to reduce coronary heart disease event risk by 37% and stroke risk by 56%.
Assuntos
Pressão Sanguínea , Nariz , Apneia Obstrutiva do Sono/terapia , Feminino , Humanos , Hipertensão/prevenção & controle , Cinética , Masculino , Pessoa de Meia-Idade , Polissonografia , Pressão , Apneia Obstrutiva do Sono/complicações , Apneia Obstrutiva do Sono/fisiopatologiaRESUMO
STUDY OBJECTIVES: To examine the utility of four methods used to detect increased upper airway resistance leading to arousal from sleep. DESIGN: Ten overnight sleep studies were conducted on normal subjects who reported increased snoring and/or witnessed apneas following alcohol ingestion. Alcohol was used to increase upper airway resistance in these normal subjects before ovemight polysomnography. Four methods to detect the presence of increased upper airway resistance were used: esophageal pressure manometry; respiratory inductive plethysmography; a piezoelectrically treated stretch sensor adhered to the supraclavicular fossa; nasal flow measured with oxygen cannula and differential pressure transducer. SETTING: Private Sleep Laboratory. PARTICIPANTS: Ten normal, healthy volunteers (5 male, 5 female). INTERVENTIONS: Alcohol ingestion as red wine (14% alcohol), 180-540 mL one to two hours before overnight polysomnography. Esophageal catheterisation. MEASUREMENTS AND RESULTS: Two hundred twenty-seven electroencephalogram arousals were preceded by inspiratory flow limitation and/or increased respiratory effort. Flattening of the nasal flow profile preceded all 227 arousals. In contrast, only 40% of arousals were preceded by an increase in the size of the stretch sensor signal, 22% by more-negative deflection of the esophageal pressure signal and 21% by increase in the signal size of respiratory inductance plethysmography. CONCLUSION: These findings indicate that the most reliable method of detecting increased upper airway resistance leading to arousal from sleep is the nasal cannula/pressure transducer method and suggest that many arousals induced by increased upper airway resistance may be caused by mechanoreceptor afferents.
Assuntos
Resistência das Vias Respiratórias/fisiologia , Ritmo Circadiano , Polissonografia/métodos , Adulto , Eletroencefalografia , Feminino , Humanos , Masculino , Pessoa de Meia-Idade , Sono REM/fisiologia , Fatores de TempoRESUMO
STUDY OBJECTIVE: Changes in sleep-disordered breathing associated with late pregnancy have not previously been systematically investigated; however, a number of case reports indicate exacerbation of obstructive sleep apnea in late pregnancy, often in association with maternal hypertension. We aimed to compare the severity of sleep-disordered breathing and associated maternal blood-pressure responses in late pregnancy with the nonpregnant state. DESIGN: Case-controlled, longitudinal study of sleep-disordered breathing during late pregnancy and postpartum. STUDY PATIENTS: Ten women referred for suspected sleep-disordered breathing during the third trimester of pregnancy. INTERVENTIONS: None. MEASUREMENTS AND RESULTS: Full overnight polysomnography and continuous systemic blood pressure were measured during the third trimester of pregnancy and 3 months following delivery. Parameters of sleep-disordered breathing, including apnea hypopnea index and minimum overnight arterial oxyhemoglobin saturation, were compared between antenatal and postnatal studies. An improvement in both apnea-hypopnea index and minimum arterial oxyhemoglobin saturation occurred consistently in all subjects postnatally. In non-rapid eye movement sleep, mean apnea-hypopnea index was reduced from 63 +/- 15 per hour antenatally to 18 +/- 4 per hour postnatally (P = .03), and in rapid eye movement sleep, from 64 +/- 11 per hour to 22 +/- 4 per hour (P = .002). Minimum arterial oxyhemoglobin saturation was increased from 86% +/- 2% antenatally to 91% +/- 1% postnatally (P = .01). Arterial blood-pressure responses to apnea peaked at 170 to 180 mm Hg antenatally, while they only peaked at 130 to 140 mm Hg postnatally. CONCLUSION: This study indicates that late pregnancy may be associated with increased severity of sleep-disordered breathing and associated blood-pressure responses.
Assuntos
Período Pós-Parto/fisiologia , Síndromes da Apneia do Sono/diagnóstico , Síndromes da Apneia do Sono/epidemiologia , Adulto , Nível de Alerta/fisiologia , Pressão Sanguínea/fisiologia , Estudos de Casos e Controles , Pressão Positiva Contínua nas Vias Aéreas/métodos , Feminino , Seguimentos , Humanos , Polissonografia , Gravidez , Resultado da Gravidez , Terceiro Trimestre da Gravidez/fisiologia , Índice de Gravidade de Doença , Síndromes da Apneia do Sono/terapia , Fases do Sono/fisiologiaRESUMO
STUDY OBJECTIVES: Recent studies suggest a specific association between intrauterine growth restriction that commonly occurs in preeclampsia and decreased maternal cardiac output. Sleep is associated with marked hypertension in preeclampsia. We therefore aimed to determine how sleep influences other hemodynamic parameters in preeclampsia, specifically to determine if sleep-induced exacerbation of hypertension was associated with reductions in cardiac output. STUDY DESIGN: Randomized controlled trial of nasal continuous positive airway pressure. SETTING: King George V, Royal Prince Alfred Hospital. PATIENTS: Twenty-four women with severe preeclampsia and 15 control nulliparous subjects. INTERVENTION: Full polysomnography including beat-to-beat blood-pressure recording. Stroke volume, heart rate, cardiac output, total peripheral resistance, and ejection duration were derived from the blood pressure waveform. Half of the 24 preeclamptic subjects were randomly assigned to receive treatment with nasal continuous positive airway pressure and the other half to receive no treatment. MEASUREMENTS AND RESULTS: Heart rate, stroke volume, and cardiac output were similar in controls and patients with preeclampsia during wakefulness, while total peripheral resistance was significantly elevated. Sleep induced marked decrements in heart rate, stroke volume, and cardiac output in preeclamptic subjects and resulted in further increments in total peripheral resistance. Cardiac output during sleep was correlated with fetal birth weight (r2 = 0.64, P < .001). When preeclamptic subjects were treated with continuous positive airway pressure, reductions in cardiac output were minimized, while increments in total peripheral resistance were also reduced. CONCLUSIONS: These data indicate that sleep is associated with adverse hemodynamic changes in women with preeclampsia. These changes are minimized with the use of continuous positive airway pressure. Reduced cardiac output during sleep may have an adverse effect on fetal development.
Assuntos
Baixo Débito Cardíaco/etiologia , Baixo Débito Cardíaco/terapia , Respiração com Pressão Positiva/métodos , Pré-Eclâmpsia/complicações , Adulto , Baixo Débito Cardíaco/fisiopatologia , Feminino , Frequência Cardíaca/fisiologia , Humanos , Polissonografia , Pré-Eclâmpsia/fisiopatologia , Gravidez , Índice de Gravidade de DoençaRESUMO
INTRODUCTION: The association between snoring, nocturnal cough, and allergic symptoms in young children is not known. OBJECTIVE: To measure the prevalence of habitual snoring and its association with nocturnal cough, asthma, and hay fever in preschool children. SETTING: A cross-sectional study. SUBJECTS: Preschool children aged 2 to 5 years. METHOD: The data were collected in a cross-sectional study. A total of 974 children were randomly selected from two areas of Lismore and Wagga Wagga in New South Wales, Australia. RESULTS: The prevalence of snoring was 10.5%, with no gender difference (p = 0.99) or trend association with age (p = 0.58). The association between snoring and nocturnal cough was highly significant (odds ratio [OR], 3.68; 95% confidence interval [CI], 2.41 to 5.63; p = 0.001). This association was significant in both the nonasthmatic and asthmatic groups when examined separately. Snoring was also significantly associated with asthma (OR, 2.03; 95% CI, 1.34 to 3.10; p = 0.001). In subjects without hay fever, the association between snoring and asthma was also highly significant (41.2% vs 24.8%; OR, 2.12; 95% CI, 1.34 to 3.37; p = 0.001). CONCLUSION: The prevalence of snoring in preschool children was 10.5% for both genders. Snoring was significantly associated with both nocturnal cough and asthma. Because snoring, asthma, and nocturnal cough may have a common etiology, it is possible that effective treatment of one symptom may lead to reductions in the presence or severity of the other symptoms.
Assuntos
Asma/complicações , Tosse/complicações , Ronco , Pré-Escolar , Intervalos de Confiança , Feminino , Humanos , Masculino , New South Wales/epidemiologia , Prevalência , Rinite Alérgica Sazonal/complicações , Ronco/complicações , Ronco/epidemiologiaRESUMO
OBJECTIVES: To evaluate sleep quality in patients with cystic fibrosis (CF). METHODS: The Pittsburgh Sleep Quality Index (PSQI) questionnaire was administered to 37 CF patients with moderate to severe lung disease in a clinically stable state. Sleep studies were performed concurrently. PSQI scores were correlated with results of anthropometric variables, arterial blood gas tensions, lung function variables, and polysomnographic variables. Potential differences in objective measurements between patients with high and low scores on the PSQI were assessed. RESULTS: Thirty-seven patients with CF were studied, aged 27+/-8 (mean+/-1 SD) years and forced expiratory volume in 1 s (FEV(1)) 36+/-12% predicted. The mean PSQI was 5.7+/-4.0. Fourteen of the 37 patients had a high PSQI, i.e. >5. Significant correlations between objective variables and both component scores and total PSQI were as follows: age and 'subjective sleep quality' (r=0.4, P<0.05), age and 'sleep duration' (r=0.3, P<0.05), FEV(1) % predicted and 'subjective sleep quality' (r=-0.4, P<0.05), carbon monoxide transferred per litre of lung volume (KCO) % predicted and 'daytime dysfunction' (r=-0.4, P<0.01), PaCO(2) and 'sleep latency' (r=0.4, P<0.01), arterial carbon dioxide tension (PaCO(2)) and 'habitual sleep efficiency' (r=0.3, P<0.05), PaCO(2) and total PSQI (r=0.4, P<0.05), absolute minimum sleep oxyhemoglobin saturation by pulse oximetry (SpO(2) %) and 'sleep latency' (r=-0.4, P<0.05), absolute minimum sleep SpO(2) % and 'sleep duration' (r=-0.4, P<0.05), absolute minimum sleep SpO(2) % and total PSQI (r=-0.4, P<0.05) and awake transcutaneous CO(2) and 'sleep duration' (r=0.45, P<0.05). Better sleep efficiency (P<0.05) and a greater % of rapid eye movement (REM) sleep (P<0.05) were found in those patients with a PSQI of < or =5. CONCLUSIONS: A number of CF patients reported poor sleep quality. A relationship was shown between subjective sleep quality and physiological variables describing disease severity. Better sleep efficiency and % REM sleep were seen in patients with low PSQI scores. These results suggest a useful role for the PSQI in assessing sleep quality in patients with CF.